Evidence map›Paper›PMID 39345552›Full record

ArticlebioRxiv : the preprint server for biology2024

Preventing Inappropriate Signals Pre- and Post-Ligand Perception by a Toggle-Switch Mechanism of ERECTA.

Liangliang Chen, Michal Maes, Alicia M Cochran, Julian R Avila, Paul Derbyshire, Jan Sklenar, Kelsey M Haas, Judit Villén, Frank L H Menke, Keiko U Torii

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Liangliang ChenHoward Hughes Medical Institute, The University of Texas at Austin, Austin, TX, 78712 USA.ORCID 0000-0001-5740-7221
Michal MaesHoward Hughes Medical Institute, The University of Texas at Austin, Austin, TX, 78712 USA.ORCID 0000-0002-7406-3982
Alicia M CochranHoward Hughes Medical Institute, The University of Texas at Austin, Austin, TX, 78712 USA.
Julian R AvilaHoward Hughes Medical Institute, The University of Texas at Austin, Austin, TX, 78712 USA.ORCID 0000-0001-9388-3946
Paul DerbyshireThe Sainsbury Laboratory, Colney Lane, NR4 7UH, Norwich, UK.
Jan SklenarThe Sainsbury Laboratory, Colney Lane, NR4 7UH, Norwich, UK.
Kelsey M HaasDepartment of Genome Sciences, University of Washington, Seattle, WA, 98195 USA.ORCID 0000-0002-1463-6726
Judit VillénDepartment of Genome Sciences, University of Washington, Seattle, WA, 98195 USA.ORCID 0000-0002-1005-1739
Frank L H MenkeThe Sainsbury Laboratory, Colney Lane, NR4 7UH, Norwich, UK.ORCID 0000-0003-2490-4824
Keiko U ToriiHoward Hughes Medical Institute, The University of Texas at Austin, Austin, TX, 78712 USA.ORCID 0000-0002-6168-427X

Funding

Towards a comprehensive roadmap of cellular signaling.R35GM119536 · NIGMS · UNIVERSITY OF WASHINGTON · PI VILLEN, JUDIT · 2016 to 2020
$2.2M
The role of phosphorylation in the cellular organization of the proteomeR35GM152061 · NIGMS · UNIVERSITY OF WASHINGTON · PI Judit Villen · 2024 to 2026
$1.3M
NIGMS NIH HHS R35 GM119536NIGMS NIH HHS R35 GM152061
6 · The paper itself

Abstract

Dynamic control of signaling events requires swift regulation of receptors at an active state. By focusing on Arabidopsis ERECTA (ER) receptor kinase, which perceives peptide ligands to control multiple developmental processes, we report a mechanism preventing inappropriate receptor activity. The ER C-terminal tail (ER_CT) functions as an autoinhibitory domain: its removal confers higher kinase activity and hyperactivity during inflorescence and stomatal development. ER_CT is required for the binding of a receptor kinase inhibitor, BKI1, and two U-box E3 ligases PUB30 and PUB31 that inactivate activated ER. We further identify ER_CT as a phosphodomain transphosphorylated by the co-receptor BAK1. The phosphorylation impacts the tail structure, likely releasing from autoinhibition. The phosphonull version enhances BKI1 association, whereas the phosphomimetic version promotes PUB30/31 association. Thus, ER_CT acts as an off-on-off toggle switch, facilitating the release of BKI1 inhibition, enabling signal activation, and swiftly turning over the receptors afterwards. Our results elucidate a mechanism fine-tuning receptor signaling via a phosphoswitch module, keeping the receptor at a low basal state and ensuring the robust yet transient activation upon ligand perception.

Indexed as

ArabidopsisC-terminal Tail DomainPhosphoregulationReceptor Kinasestomatal development

Identifiers

PMID39345552
PMCPMC11429954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.